logo
Select company
Select metric
$ -33.8MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
21
Sector
21
Industry
22
History
50
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -33.8M
3/31/2025$ -128.81M
12/31/2024$ 10.15M
9/30/2024$ -47.59M
6/30/2024$ -20.02M
3/31/2024$ -32.34M
12/31/2023$ -91.64M
9/30/2023$ -51.05M
6/30/2023$ -85.03M
3/31/2023$ 27.88M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -74.91M.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average CF - Chg. Cash has been $ -27.62M.
  • The median CF - Chg. Cash for SAGE THERAPEUTICS INC during this period was $ -49.32M
  • SAGE THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 1.53B.
  • The lowest CF - Chg. Cash recorded by SAGE THERAPEUTICS INC in the same timeframe $ -1.37B

SAGE THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
KURA : KURA ONCOLOGY INC $ 36.77MTBPH : THERAVANCE BIOPHARMA INC $ 235.58MNKTR : NEKTAR THERAPEUTICS $ 15.05MZVRA : ZEVRA THERAPEUTICS INC $ 8.45MLXRX : LEXICON PHARMACEUTICALS INC $ 14.75MADCT : ADC THERAPEUTICS SA $ -35.83MYMAB : Y-MABS THERAPEUTICS INC $ -15.51MGOSS : GOSSAMER BIO INC $ -60.57MEYPT : EYEPOINT PHARMACEUTICALS INC $ -19.63MAUTL : AUTOLUS THERAPEUTICS PLC $ -581.63M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

SAGE - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -1.37B

Minimum

Dec 31, 2021

$ 1.53B

Maximum

Dec 31, 2020

$ -27.62M

Average

$ -49.32M

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M